Single use bioreactor control system

Effortlessly customize your control strategy for single-use bioprocesses, ensuring seamless integration and compatibility with your existing systems.

Controls and Optimizes Bioreactor Operations

The Single Use Bioreactor Control System offered by Marubishi Bioengineering is a customizable solution designed to seamlessly integrate into your biopharmaceutical production line, particularly when managing complex cell cultures and monoclonal antibody production. Its standout feature is the ability to tailor the control system according to your specific bioprocessing strategies, ensuring optimal performance and compliance with unique operational requirements.

This system excels in managing single-use bioreactors, commonly used in generating recombinant proteins and viral vectors intended for gene therapy. It supports continuous operations with an integrated SIP (Sterilization-In-Place) and CIP (Clean-In-Place) functionality to maintain sterility and operational efficiency.

Built for versatility, the system can manage various processing capacities, integrating smoothly with existing upstream and downstream processes. With a focus on energy efficiency, it incorporates advanced software for precise environment control, reducing energy consumption and system downtime.

Engineered from high-grade materials suitable for stringent biopharmaceutical conditions, it stands robust against potential corrosion, ensuring longevity and reliability. Certified to adhere to cGMP and FDA standards, this system is designed for the highest levels of compliance in the bioprocessing and life sciences industries.

For enhanced usability, it includes comprehensive support for system customization, remote monitoring, and flexible operational adjustments, ensuring it meets the varied demands of biotech and pharmaceutical applications.

Benefits

  • Ensures seamless integration with existing bioprocess control strategies, reducing implementation time.
  • Supports continuous operation, maximizing production efficiency and output quality.
  • Reduces operational costs with energy-efficient motor control and advanced automation.
  • Maintains compliance with cGMP and FDA standards for confidence in regulatory adherence.
  • Enhances process adaptability with customizable system configurations tailored to specific production needs.

General


Applications
Biopharmaceuticals,Monoclonal antibodies (mabs),Bioprocess solutions,Cell cultures
End products
Cell therapy products,Personalized medicine formulations,Viral vectors for gene therapy,High-yield cell culture media,Biosimilars,Enzyme products,Recombinant proteins,Monoclonal antibody drugs
Steps before
Cell Culture Preparation,Inoculum Development,Media Preparation
Steps after
Protein Purification,Filtration,Formulation
Input ingredients
cells,biomass,media,feedstock
Output ingredients
bioproduct,concentrated cells,purified product,cell-free supernatant
Market info
Marubishi Bioengineering is known for its expertise in manufacturing high-quality bioreactors and fermentation systems for the biotechnology and pharmaceutical industries, reputed for their precision-engineering and customization to meet specific client requirements.

Technical Specifications


Control system
Customized for specific bioprocess
Automation
Automatic operation system for SIP and CIP
Single use compatibility
Bioreactor and downstream process
Centrifuging system
Continuous
Membrane type
Micro-filtration and ultrafiltration
Control strategy
Tailored to customer's specific needs
SIP capability
Yes
CIP capability
Yes
Separation type
Cell separation by micro-filtration
Concentration type
Product concentration by ultrafiltration

Operating Characteristics


Working mechanism
Continuous centrifuging,membrane separation
Integrated steps
Micro-filtration and ultrafiltration
CIP/SIP
Automatic operation system for CIP/SIP
Batch vs. continuous operation
Continuous
Automation level
Customizable control system
Cleaning method
CIP / SIP
Custom control strategy compatibility
Customizable system integration

Material Compatibility


Density/particle size
0.5–2.5 g/cm³ / 50–1000 µm

Product type Characteristics


Field of Application
Monoclonal Antibodies

Physical Characteristics


Control panel type
Customizable for user needs
Compact footprint
Yes
Discharge method
Automated

Custom Options


Control system
Customizable to suit specific control strategy
HMI type
Customizable based on user requirements
Integration possibilities
Automated valves,sensors,customized for SIP/CIP
Control panel type
Customizable based on bioprocess requirements
Assembly unit
Customizable with various units like centrifuging machine,piping systems